J. David Bessman
University of Texas Medical Branch
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J. David Bessman.
Psychiatry Research-neuroimaging | 1986
Robert M. Rose; Sam Castellani; J.Alexander Boeringa; Parvis Malek-Ahmadi; D.Alan Lankford; J. David Bessman; Richard R. Fritz; Constance B. Denney; Richard M. Denney; Creed W. Abell
Platelet monoamine oxidase (MAO B) in 59 normal and 57 RDC-diagnosed medicated and unmedicated schizophrenic subjects was analyzed for whole platelet and extracted activities, specific concentration, and molecular activity. A novel radioimmunoassay using a monoclonal antibody elicited to human platelet MAO was used. Female schizophrenics showed no differences from female normals in MAO measures; however, these data could not be clearly evaluated because of confounding effects of age and drugs. Male schizophrenics treated with neuroleptics expressed significantly reduced whole platelet MAO activity, compared to untreated male patients. Compared with normal males, male schizophrenics showed significantly lowered molecular activities, along with elevated specific concentrations, which did not appear to be explained solely by drug usage. Additional mechanisms explaining the diminished molecular activity in male schizophrenics may be the presence of an endogenous irreversible inhibitor or a genetically determined, possibly structural, variant of MAO B.
Psychiatry Research-neuroimaging | 1986
Richard R. Fritz; Creed W. Abell; Richard M. Denney; Constance B. Denney; J. David Bessman; J.Alexander Boeringa; Sam Castellani; D.Alan Lankford; Parviz Malek-Ahmadi; Robert M. Rose
New methods for determination of specific concentration and molecular activity of monoamine oxidase (MAO) in platelets are described and evaluated in parallel with specific activity measures, performed in whole platelets and platelet extracts. Platelet MAO specific concentration is determined in platelet extracts by a radioimmunoassay, using a monoclonal antibody that recognizes human MAO B, the form that occurs in platelets, but not MAO A. All four platelet MAO measures are found to be reliable and stable, and thus are suitable for long-term comparisons of normal and clinical populations, such as those reported in Part II of this report. The new measures of enzyme concentration and molecular activity make available important information about the state of MAO B molecules in a given individual that reflects the genetic expression and control of the enzyme.
American Journal of Clinical Pathology | 1981
J. David Bessman; Larry J. Williams; P. Ridgway Gilmer
American Journal of Hematology | 1984
J. David Bessman
Cancer Detection and Prevention | 2004
Derrick W. Spell; Dennie V. Jones; William F Harper; J. David Bessman
American Journal of Clinical Pathology | 1982
J. David Bessman; Larry J. Williams; P. Ridgway Gilmer
JAMA | 1985
Suzanne McClure; Edward Custer; J. David Bessman
American Journal of Clinical Pathology | 1988
J. David Bessman
JAMA | 1991
J. David Bessman; Suzanne McClure
American Journal of Clinical Pathology | 1986
J. David Bessman; P. R. Gilmer; Frank H. Gardner